Armenia vs Sur: HIV-positive TB patients on ART (antiretroviral therapy)
Armenia
100.0%
in 2024
Sur
82.0%
in 2024
Armenia rank
1st
Sur rank
2nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Armenia
- Sur
How they compare
Armenia currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes Armenia's figure about 1.2 times Sur's.
The two have swapped places 8 times across 16 shared years of data; in 2005 it was Armenia ahead.
Armenia ranks 1st and Sur ranks 2nd of 144 countries.
Across the 3 decades both report, Armenia averaged higher in 2 and Sur in 1.
Head to head by decade
| Decade | Armenia | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 25.4% | 30.7% | 5.2% | Sur |
| 2010s | 80.6% | 66.3% | 14.3% | Armenia |
| 2020s | 90.3% | 75.7% | 14.7% | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Armenia or Sur?
- Armenia, at 100.0% against 82.0% in Sur as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Armenia and Sur?
- 18.0%, with Armenia ahead.
- How many years of comparable data are there for Armenia and Sur?
- 16 years are reported by both, from 2005 to 2024.
- How do Armenia and Sur rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Armenia ranks 1st and Sur ranks 2nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.